尼泊尔加德满都某参比实验室细菌感染回顾性分析(2021-2024)

IF 1.6 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Sohani Bajracharya, Ajaya Basnet, Ranjan Bhele Shrestha, Jeevan Adhikari
{"title":"尼泊尔加德满都某参比实验室细菌感染回顾性分析(2021-2024)","authors":"Sohani Bajracharya, Ajaya Basnet, Ranjan Bhele Shrestha, Jeevan Adhikari","doi":"10.4269/ajtmh.25-0116","DOIUrl":null,"url":null,"abstract":"<p><p>Of all the recognized public health threats, antimicrobial resistance (AMR) is among the most serious. Antimicrobial resistance may have a higher prevalence in low- and middle-income countries, where antimicrobial misuse is compounded by inadequate infection control measures. In this study, we examined AMR trends in bacterial infections in a reference laboratory in Kathmandu, Nepal, from 2021 to 2024. We collected the clinical records of infected patients, including demographic details, pathogen profiles, and antibiograms, from the electronic laboratory information system and analyzed them using SPSS version 17.0 (IBM Corp., Armonk, NY). Among 3,720 patients, 703 (19.7%; median age: 40 years; 395 [54.0%] female) had infections primarily caused by bacteria (91.7%; 723/731), followed by yeast (3.8%; 28/731). Urinary tract infections (55.9%; 290/703) were the most common. The predominant pathogen was Escherichia coli (41.3%; 290/703). Resistance rates in Enterobacterales, nonfermenters, and Gram-positive cocci were 31.0%, 43.4%, and 13.5%, respectively, for aminoglycosides; 49.7%, 42.8%, and 40.2%, respectively, for fluoroquinolones; 64.9%, 59.0%, and 65.6%, respectively, for cephalosporins; 47.3%, 77.4%, and 27.2%, respectively, for trimethoprim-sulfamethoxazole; and 83.0%, 100.0%, and 85.0%, respectively, for penicillins. Extensively drug-resistant (XDR; 19.1%; 134/703) and multidrug-resistant (29.2%; 205/703) bacteria exhibited >90% resistance to ciprofloxacin, erythromycin, and beta-lactams. Over time (2022-2024), resistance increased for aminoglycosides (27.7-32.3%), fluoroquinolones (43.5-54.1%), and penicillin with beta-lactamase inhibitors (PwBLIs; 35.9-58.7%) but decreased for cephalosporins (67.5-62.8%), carbapenems (23.3-18.7%), penicillins (85.2-82.1%), trimethoprim-sulfamethoxazole (59.6-42.2%), and nitrofurantoin (39.0-3.7%). A low rate of bacterial infections was detected among hospital visitors. Urinary tract infections were the most prevalent type of infection. Multidrug-resistant bacteria predominated over XDR bacteria. Resistance to beta-lactams declined over time; however, resistance to aminoglycosides, fluoroquinolones, and PwBLIs increased.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":"749-757"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12493258/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Retrospective Analysis of Bacterial Infections (2021-2024) in a Reference Laboratory in Kathmandu, Nepal.\",\"authors\":\"Sohani Bajracharya, Ajaya Basnet, Ranjan Bhele Shrestha, Jeevan Adhikari\",\"doi\":\"10.4269/ajtmh.25-0116\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Of all the recognized public health threats, antimicrobial resistance (AMR) is among the most serious. Antimicrobial resistance may have a higher prevalence in low- and middle-income countries, where antimicrobial misuse is compounded by inadequate infection control measures. In this study, we examined AMR trends in bacterial infections in a reference laboratory in Kathmandu, Nepal, from 2021 to 2024. We collected the clinical records of infected patients, including demographic details, pathogen profiles, and antibiograms, from the electronic laboratory information system and analyzed them using SPSS version 17.0 (IBM Corp., Armonk, NY). Among 3,720 patients, 703 (19.7%; median age: 40 years; 395 [54.0%] female) had infections primarily caused by bacteria (91.7%; 723/731), followed by yeast (3.8%; 28/731). Urinary tract infections (55.9%; 290/703) were the most common. The predominant pathogen was Escherichia coli (41.3%; 290/703). Resistance rates in Enterobacterales, nonfermenters, and Gram-positive cocci were 31.0%, 43.4%, and 13.5%, respectively, for aminoglycosides; 49.7%, 42.8%, and 40.2%, respectively, for fluoroquinolones; 64.9%, 59.0%, and 65.6%, respectively, for cephalosporins; 47.3%, 77.4%, and 27.2%, respectively, for trimethoprim-sulfamethoxazole; and 83.0%, 100.0%, and 85.0%, respectively, for penicillins. Extensively drug-resistant (XDR; 19.1%; 134/703) and multidrug-resistant (29.2%; 205/703) bacteria exhibited >90% resistance to ciprofloxacin, erythromycin, and beta-lactams. Over time (2022-2024), resistance increased for aminoglycosides (27.7-32.3%), fluoroquinolones (43.5-54.1%), and penicillin with beta-lactamase inhibitors (PwBLIs; 35.9-58.7%) but decreased for cephalosporins (67.5-62.8%), carbapenems (23.3-18.7%), penicillins (85.2-82.1%), trimethoprim-sulfamethoxazole (59.6-42.2%), and nitrofurantoin (39.0-3.7%). A low rate of bacterial infections was detected among hospital visitors. Urinary tract infections were the most prevalent type of infection. Multidrug-resistant bacteria predominated over XDR bacteria. Resistance to beta-lactams declined over time; however, resistance to aminoglycosides, fluoroquinolones, and PwBLIs increased.</p>\",\"PeriodicalId\":7752,\"journal\":{\"name\":\"American Journal of Tropical Medicine and Hygiene\",\"volume\":\" \",\"pages\":\"749-757\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12493258/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Tropical Medicine and Hygiene\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4269/ajtmh.25-0116\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/10/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.25-0116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

在所有已知的公共卫生威胁中,抗菌素耐药性是最严重的威胁之一。在低收入和中等收入国家,抗菌素耐药性的流行率可能更高,在这些国家,抗菌素滥用加上感染控制措施不足,情况更加复杂。在这项研究中,我们在尼泊尔加德满都的一个参考实验室检查了2021年至2024年细菌感染的AMR趋势。我们从电子实验室信息系统中收集感染患者的临床记录,包括人口统计学细节、病原体谱和抗生素谱,并使用SPSS 17.0版(IBM Corp., Armonk, NY)进行分析。3720例患者中,703例(19.7%;中位年龄:40岁;395例(54.0%)女性)主要由细菌引起感染(91.7%);723/731),其次是酵母(3.8%;28/731)。尿路感染(55.9%);290/703)最为常见。优势病原菌为大肠杆菌(41.3%);290/703)。肠杆菌、非发酵菌和革兰氏阳性球菌对氨基糖苷类的耐药率分别为31.0%、43.4%和13.5%;氟喹诺酮类药物分别为49.7%、42.8%和40.2%;头孢菌素分别为64.9%、59.0%和65.6%;甲氧苄啶-磺胺甲恶唑分别为47.3%、77.4%和27.2%;青霉素类分别为83.0%、100.0%和85.0%。广泛耐药;19.1%;134/703)和耐多药(29.2%;205/703)细菌对环丙沙星、红霉素和β -内酰胺类药物的耐药性为90%。随着时间的推移(2022-2024),氨基糖苷类药物(27.7-32.3%)、氟喹诺酮类药物(43.5-54.1%)和青霉素联合β -内酰胺酶抑制剂(PwBLIs;头孢菌素类(67.5-62.8%)、碳青霉烯类(23.3-18.7%)、青霉素类(85.2-82.1%)、甲氧苄啶-磺胺甲恶唑类(59.6-42.2%)、呋喃妥英类(39.0-3.7%)下降。在医院访客中发现细菌感染率较低。尿路感染是最常见的感染类型。多药耐药菌比XDR菌占优势。对β -内酰胺的耐药性随着时间的推移而下降;然而,对氨基糖苷类、氟喹诺酮类和pwbli类药物的耐药性增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Retrospective Analysis of Bacterial Infections (2021-2024) in a Reference Laboratory in Kathmandu, Nepal.

Of all the recognized public health threats, antimicrobial resistance (AMR) is among the most serious. Antimicrobial resistance may have a higher prevalence in low- and middle-income countries, where antimicrobial misuse is compounded by inadequate infection control measures. In this study, we examined AMR trends in bacterial infections in a reference laboratory in Kathmandu, Nepal, from 2021 to 2024. We collected the clinical records of infected patients, including demographic details, pathogen profiles, and antibiograms, from the electronic laboratory information system and analyzed them using SPSS version 17.0 (IBM Corp., Armonk, NY). Among 3,720 patients, 703 (19.7%; median age: 40 years; 395 [54.0%] female) had infections primarily caused by bacteria (91.7%; 723/731), followed by yeast (3.8%; 28/731). Urinary tract infections (55.9%; 290/703) were the most common. The predominant pathogen was Escherichia coli (41.3%; 290/703). Resistance rates in Enterobacterales, nonfermenters, and Gram-positive cocci were 31.0%, 43.4%, and 13.5%, respectively, for aminoglycosides; 49.7%, 42.8%, and 40.2%, respectively, for fluoroquinolones; 64.9%, 59.0%, and 65.6%, respectively, for cephalosporins; 47.3%, 77.4%, and 27.2%, respectively, for trimethoprim-sulfamethoxazole; and 83.0%, 100.0%, and 85.0%, respectively, for penicillins. Extensively drug-resistant (XDR; 19.1%; 134/703) and multidrug-resistant (29.2%; 205/703) bacteria exhibited >90% resistance to ciprofloxacin, erythromycin, and beta-lactams. Over time (2022-2024), resistance increased for aminoglycosides (27.7-32.3%), fluoroquinolones (43.5-54.1%), and penicillin with beta-lactamase inhibitors (PwBLIs; 35.9-58.7%) but decreased for cephalosporins (67.5-62.8%), carbapenems (23.3-18.7%), penicillins (85.2-82.1%), trimethoprim-sulfamethoxazole (59.6-42.2%), and nitrofurantoin (39.0-3.7%). A low rate of bacterial infections was detected among hospital visitors. Urinary tract infections were the most prevalent type of infection. Multidrug-resistant bacteria predominated over XDR bacteria. Resistance to beta-lactams declined over time; however, resistance to aminoglycosides, fluoroquinolones, and PwBLIs increased.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Tropical Medicine and Hygiene
American Journal of Tropical Medicine and Hygiene 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.20
自引率
3.00%
发文量
508
审稿时长
3 months
期刊介绍: The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine. The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development. The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal. Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信